Predict your next investment

INTERNET | Internet Software & Services / Healthcare
ambrahealth.com

See what CB Insights has to offer

Executives

7

Board of Directors

2

Ambra Health Board of Directors

2 Board of directors

Ambra Health has 2 board of directors, including Myles Greenberg.

Name

Firm

Work History

Other Seats

Myles Greenberg

Dr. Myles Greenberg has more than 20 years’ experience in growing healthcare, medical technology and life sciences firms as an entrepreneur, operating executive, board member, clinician and investor. Prior to joining Alucent, he served as Chief Development Officer at IntegraMed America, a private equity backed healthcare services firm. He still serves today on the Board of Directors at Urgent Care Centers of New England, a company he co-founded. Dr. Greenberg has spent most of his career as an early-stage venture capital investor with CHL Medical Partners, HealthInvest Equity Partners, and Pappas Ventures. Dr. Greenberg served as a board member, lead director, and in interim management roles in numerous biotech, medical device, and healthcare services firm. Eight of the companies where Dr. Greenberg played a major investor and advisory role were acquired or went public. Dr. Greenberg began his career as a faculty physician and hospital administrator at Beth Israel Deaconess Medical Center, Harvard Medical School in Boston. He holds a Master of Business Administration from Harvard Business School, Doctor of Medicine from Yale University School of Medicine, and a Bachelor of Applied Science from the University of Pennsylvania. He is a Diplomate of the American Board of Emergency Medicine.

Ambra Health

Stephen Bloch

As an entrepreneur, venture capitalist and former practicing physician, Steve knows firsthand the challenges of building successful healthcare companies. Unfazed by complexity in healthcare, whether technical, regulatory, or market driven, Steve's mission has been to make healthcare delivery more effective and affordable. Before co-founding EvolveImmune, Steve helped start and finance leading healthcare companies as a general partner at Canaan Partners. Steve currently serves on the boards of companies in biopharma (Liquidia (LQDA – NASDAQ, board chairman), digital health (Truveris, Ambra Health, Corvium and Genome Medical), and medical devices (Onkos Surgical). Past board roles include Amicus Therapeutics (FOLD-NASDAQ), Marinus Pharmaceuticals (MRNS-NASDAQ) and Advanced BioHealing (M&A with Shire). Steve is a member of Dartmouth Medical School’s Board of Advisors. Before joining Canaan in 2002, Steve helped found and manage multiple start-ups, including Radiology Management Sciences (RMS) where he was CEO for 6 years, OmniSonics and TeleRad. Previously, Steve was a strategic pharmaceutical consultant for Arthur D. Little. Steve was an Ewing Marion Kauffman Fellow, an educational program to develop future leaders in venture capital. Steve obtained his AB from Dartmouth College, a MA in the history of science from Harvard, and his medical degree from the University of Rochester. Steve completed his residency at Massachusetts General Hospital/Harvard Medical School (radiology) and Lenox Hill Hospital/Cornell Medical School (internal medicine).

Ambra Health

Name

Myles Greenberg

Stephen Bloch

Firm

Work History

Dr. Myles Greenberg has more than 20 years’ experience in growing healthcare, medical technology and life sciences firms as an entrepreneur, operating executive, board member, clinician and investor. Prior to joining Alucent, he served as Chief Development Officer at IntegraMed America, a private equity backed healthcare services firm. He still serves today on the Board of Directors at Urgent Care Centers of New England, a company he co-founded. Dr. Greenberg has spent most of his career as an early-stage venture capital investor with CHL Medical Partners, HealthInvest Equity Partners, and Pappas Ventures. Dr. Greenberg served as a board member, lead director, and in interim management roles in numerous biotech, medical device, and healthcare services firm. Eight of the companies where Dr. Greenberg played a major investor and advisory role were acquired or went public. Dr. Greenberg began his career as a faculty physician and hospital administrator at Beth Israel Deaconess Medical Center, Harvard Medical School in Boston. He holds a Master of Business Administration from Harvard Business School, Doctor of Medicine from Yale University School of Medicine, and a Bachelor of Applied Science from the University of Pennsylvania. He is a Diplomate of the American Board of Emergency Medicine.

As an entrepreneur, venture capitalist and former practicing physician, Steve knows firsthand the challenges of building successful healthcare companies. Unfazed by complexity in healthcare, whether technical, regulatory, or market driven, Steve's mission has been to make healthcare delivery more effective and affordable. Before co-founding EvolveImmune, Steve helped start and finance leading healthcare companies as a general partner at Canaan Partners. Steve currently serves on the boards of companies in biopharma (Liquidia (LQDA – NASDAQ, board chairman), digital health (Truveris, Ambra Health, Corvium and Genome Medical), and medical devices (Onkos Surgical). Past board roles include Amicus Therapeutics (FOLD-NASDAQ), Marinus Pharmaceuticals (MRNS-NASDAQ) and Advanced BioHealing (M&A with Shire). Steve is a member of Dartmouth Medical School’s Board of Advisors. Before joining Canaan in 2002, Steve helped found and manage multiple start-ups, including Radiology Management Sciences (RMS) where he was CEO for 6 years, OmniSonics and TeleRad. Previously, Steve was a strategic pharmaceutical consultant for Arthur D. Little. Steve was an Ewing Marion Kauffman Fellow, an educational program to develop future leaders in venture capital. Steve obtained his AB from Dartmouth College, a MA in the history of science from Harvard, and his medical degree from the University of Rochester. Steve completed his residency at Massachusetts General Hospital/Harvard Medical School (radiology) and Lenox Hill Hospital/Cornell Medical School (internal medicine).

Other Seats

Ambra Health

Ambra Health

Ambra Health Management Team

7 Team Members

Ambra Health has 7 executives. Ambra Health's current Chief Executive Officer is Morris Panner.

Name

Work History

Title

Status

Morris Panner

Groupflier, OpenAir, U.S. Department of Justice, and Wachtell Lipton

Chief Executive Officer

Current

Laura Schulhof

Chief Financial Officer

Current

Geoff Crawshaw

U.S. Army

Chief Technology Officer

Current

Gregory W Vesper

Chief Technology Officer

Former

Mini Peiris

Chief Marketing Officer

Former

Name

Morris Panner

Laura Schulhof

Geoff Crawshaw

Gregory W Vesper

Mini Peiris

Work History

Groupflier, OpenAir, U.S. Department of Justice, and Wachtell Lipton

U.S. Army

Title

Chief Executive Officer

Chief Financial Officer

Chief Technology Officer

Chief Technology Officer

Chief Marketing Officer

Status

Current

Current

Current

Former

Former

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.